USPTOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The US trademark ATRECA was filed as Word mark on 03/23/2011 at the U.S. Patent and Trademark Office. The current status of the mark is "ABANDONED - NO STATEMENT OF USE FILED".
| Trademark form | Word mark |
| File reference | 85275010 |
| Application date | March 23, 2011 |
| Publication date | October 16, 2012 |
Trademark owner
500 Saginaw Dr., Suite 100
94063 Redwood City
US
94063 Redwood City
US
Trademark representatives
goods and services
1
Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medical laboratory, or research use, for predicting the response of patients to therapeutics; biological tissue for research and scientific diagnosis use; antibodies for research and scientific diagnosis use; combinations of biological tissue for research and scientific diagnosis use; combinations of antibodies for research and scientific diagnosis use; kits containing buffers and chemical reagents for use in molecular biology research applications
5
Diagnostic preparations and diagnostic kits comprised of buffers and reagents for medical use, for predicting the response of patients to therapeutics; biologics for medical use, namely, biological preparation for the treatment of infectious disease; biologics for medical use, namely, biological preparation for the treatment of cancer; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologics for medical use, namely, biological preparation for the treatment of animal health; biologics, namely, biological tissue for medical diagnosis; biologics, namely, antibodies for medical diagnosis; biologics, namely, vaccines for medical diagnosis, research and scientific diagnosis; combinations of biologics for medical use, namely, biological preparation for the treatment of infectious disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cancer; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; combinations of biologics for medical use, namely, biological preparation for the treatment of animal health; combinations of biologics, namely, biological tissue, antibodies, and vaccines, for medical diagnosis
ID: 1385275010